Dear Friends,
with this first newsletter of the European Dialysis working group (EUDIAL) we ae excited to establish a regular communication with the members of our big haemodialysis community and one of the more populated ERA-EDTA working groups.
In EUDIAL newsletters you will find news on EUDIAL group, updates on upcoming CME Courses on haemodialysis as well as recently published relevant articles and late-breaking clinical trials.
We would also like to invite you to kindly encourage your colleagues interested in research, teaching, communication and education in the field of haemodialysis and related comorbidities to become an EUDIAL Ordinary Member. Click here to become one.
With kind regards,
Dimitrios Kirmizis (Greece), newsletter Editor
Carlo Basile (Italy), Chair
Sandip Mitra (United Kingdom), Vice-Chair
Elected new Board Members
We are pleased to welcome on board Christian Combe (France), Frank van der Sande (The Netherlands), Daniel Schneditz (Austria) and Adrian Covic (Romania).
 |
Interested in Incremental Hemodialysis? Read the related article on NDT. |
We would like to draw your attention to the following educational meetings to be held in 2018: EUDIAL CME Course entitled “Haemodialysis Update 2018: from basics to advances in the treatment of CKD”, to be held at the Annual Meeting of the Italian Society of Nephrology (Società Italiana di Nefrologia – SIN), in Rimini (Italy) on October 3, 2018. EUDIAL warmly suggests also the following upcoming educational events: • 12th International Congress of the ISHD, Cartagena, Colombia, April 18-21, 2018 • Dialysis 2018, University College London, Centre for Nephrology, Royal Free, London, June 6-8, 2018 |
|
Updates from recent ASN Kidney Week 2017
We would like to draw your attention to the results of high-impact clinical trials presented at ASN Kidney Week on October 31-November 5, 2017 in New Orleans (USA) that could affect kidney-related medical care:
- Haemodiafiltration (HDF) Improves the Cardiovascular Risk Profile Compared to Conventional Haemodialysis (HD) in Children – The HDF, Heart, and Height (3H) Trial. J Am Soc Nephrol 2017; 28 (Suppl): 83
- Acetate Free Dialysis and Mortality in the French Renal Epidemiology Information Network Registry (REIN). J Am Soc Nephrol 2017; 28 (Suppl): 606
- Engineering Design of Robust Ultrafiltration Profiles in Hemodialysis. J Am Soc Nephrol 2017; 28 (Suppl): 657
- UK Clinical Experiences of a New Expanded Hemodialysis Therapy with a Novel Medium Cut-Off Dialyzer. J Am Soc Nephrol 2017; 28 (Suppl): 875
We would also like to draw your attention to published studies that could affect kidney-related medical care:
- Short daily-, nocturnal- and conventional-home hemodialysis have similar patient and treatment survival. Kidney Int 2018; 93: 188-194
- A user-friendly tool for incremental haemodialysis prescription. Nephrol Dial Transplant. 2018 Jan 5. doi: 10.1093/ndt/gfx343
Other ongoing trials of clinical interest:
- Incremental Haemodialysis in Incident Patients (IHDIP) [ClinicalTrials.gov Identifier: NCT03239808]: This study investigates with the highest level of scientific evidence, the number of sessions a patient should receive when starting the HD treatment, depending on his/her RRF. Click here for more information.
- Expanded hemodialysis registry protocol in Colombia (COREXH) [Protocol/serial number RTSCOL003]: a prospective cohort, multicenter, observational study: Determine clinical outcomes in patients on treatment with expanded hemodialysis using the Theranova dialyzer, based on a registry of conventional clinical practice in Colombia. Click here for more information.
- Expanded Hemodialysis Versus Online Hemodiafiltration [Clinical Study Identifier: NCT03274518]: The aim of this present study is to compare the extraction of middle-size molecules, the hemodynamic behavior, fluid and nutritional status of patients submitted to olHDF or HDx, in a crossover study. Click here for more information.
 |
 |
 |
 |
 |
 |
 |
 |